Search research articles
Contact Us
Filters
Showing results (451-460 of 481) with videos related to
Page
of 49
Sort By:
The Review of Scientific Instruments
|
April 30, 2022
Two-dimensional monitoring of a laser-solid x-ray source spot via penumbral coded aperture imaging technique
Xue-Jie Bai, Yi-Hong Yan, Hong-Yi Lei, et al.
Imeta
|
June 13, 2024
CBD2: A functional biomarker database for colorectal cancer
Xueli Zhang, Min Li, Siting Ye, et al.
Blood
|
January 29, 2021
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma
Di Wang, Jue Wang, Guang Hu, et al.
Expert Opinion on Therapeutic Targets
|
June 20, 2020
The role of microRNA in cisplatin resistance or sensitivity
Shanshan Wang, Ming-Yue Li, Yi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 9, 2024
Long-term safety and efficacy of the fully human CAR-T therapy CT103A in relapsed/refractory multiple myeloma
Qiuxia Yu, Di Wang, Zhe Li, et al.
Cell Discovery
|
September 5, 2020
USP7 negatively controls global DNA methylation by attenuating ubiquitinated histone-dependent DNMT1 recruitment
Jialun Li, Ruiping Wang, Jianyu Jin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 6, 2020
In vivo hepatotoxicity screening of different extracts, components, and constituents of Polygoni Multiflori Thunb. in zebrafish (Danio rerio) larvae
Hong-Ying Li, Jian-Bo Yang, Wan-Fang Li, et al.
Science Translational Medicine
|
May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy
Jiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Cell Chemical Biology
|
June 24, 2023
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2
Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 481) with videos related to
Sort By:
Page
of 49
The Review of Scientific Instruments
|
April 30, 2022
Two-dimensional monitoring of a laser-solid x-ray source spot via penumbral coded aperture imaging technique
Xue-Jie Bai, Yi-Hong Yan, Hong-Yi Lei, et al.
Imeta
|
June 13, 2024
CBD2: A functional biomarker database for colorectal cancer
Xueli Zhang, Min Li, Siting Ye, et al.
Blood
|
January 29, 2021
A phase 1 study of a novel fully human BCMA-targeting CAR (CT103A) in patients with relapsed/refractory multiple myeloma
Di Wang, Jue Wang, Guang Hu, et al.
Expert Opinion on Therapeutic Targets
|
June 20, 2020
The role of microRNA in cisplatin resistance or sensitivity
Shanshan Wang, Ming-Yue Li, Yi Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 9, 2024
Long-term safety and efficacy of the fully human CAR-T therapy CT103A in relapsed/refractory multiple myeloma
Qiuxia Yu, Di Wang, Zhe Li, et al.
Cell Discovery
|
September 5, 2020
USP7 negatively controls global DNA methylation by attenuating ubiquitinated histone-dependent DNMT1 recruitment
Jialun Li, Ruiping Wang, Jianyu Jin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
November 6, 2020
In vivo hepatotoxicity screening of different extracts, components, and constituents of Polygoni Multiflori Thunb. in zebrafish (Danio rerio) larvae
Hong-Ying Li, Jian-Bo Yang, Wan-Fang Li, et al.
Science Translational Medicine
|
May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy
Jiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Cell Chemical Biology
|
June 24, 2023
TRIM21 is a druggable target for the treatment of metastatic colorectal cancer through ubiquitination and activation of MST2
Yu-Xuan Liu, Shan Wan, Xiao-Qin Yang, et al.
Nature Medicine
|
October 1, 2024
Allogeneic CD5-specific CAR-T therapy for relapsed/refractory T-ALL: a phase 1 trial
Jing Pan, Yue Tan, Lingling Shan, et al.
Page
of 49